US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

27.35

-0.0400-0.15%

Post-market: 27.350.00000.00%17:13 EDT

Volume:82.91K

Turnover:2.27M

Market Cap:1.78B

PE:-8.04

High:27.91

Open:27.44

Low:26.94

Close:27.39

52wk High:29.80

52wk Low:11.51

Shares:64.96M

Float Shares:33.91M

Volume Ratio:0.41

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4023

EPS(LYR):-2.5724

ROE:-53.76%

ROA:-32.07%

PB:4.94

PE(LYR):-10.63

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pharvaris (PHVS) and Cryo-Cell International (CCEL)

Pharvaris Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

Pharvaris (PHVS) Valuation Check After Positive Deucrictibant Phase 2 And RAPIDe 3 Results

Simply Wall St.

Pharvaris reports Phase 3 RAPIDe-3 success for deucrictibant in hereditary angioedema attacks

BRAIN Biotech posts Q1 net loss of EUR 2.9 million, revenue down 9% to EUR 11.9 million

Morgan Stanley Remains a Buy on Pharvaris (PHVS)

A Look At Pharvaris (PHVS) Valuation As Deucrictibant Advances With New Phase 3 And Phase 2 Data

Simply Wall St.

Pharvaris Unveils Positive Phase 3 RAPIDe-3 Data for Deucrictibant in HAE Treatment

Morgan Stanley Reaffirms Their Buy Rating on Pharvaris (PHVS)

Assessing Pharvaris (PHVS) Valuation After Earnings Beat And Renewed Analyst Optimism

Simply Wall St.

Analysts Conflicted on These Healthcare Names: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN)

Pharvaris Sets 2026 Roadmap as Deucrictibant Advances Toward NDA Filing and Phase 3 Readouts

Pharvaris joins Nasdaq Biotechnology Index

Pharvaris Outlines 2026 Strategic Priorities

THOMSON REUTERS

Pharvaris Nv - Estimated Cash Runway Into H1 2027

THOMSON REUTERS

Pharvaris Nv - Topline Data From Chapter-3 Study Expected in 3Q2026

THOMSON REUTERS

Pharvaris Nv - Nda Filing for Deucrictibant Expected in 1H2026

THOMSON REUTERS

Pharvaris (PHVS): Reassessing Valuation After Strong RAPIDe-3 Phase 3 Success in Hereditary Angioedema

Simply Wall St.

Pharvaris' Phase 3 Trial of Deucrictibant for HAE Attacks Confirms a Differentiated On-Demand Profile, Morgan Stanley Says

MT Newswires Live

Pharvaris Nv : Oppenheimer Raises Target Price to $50 From $44

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PHVS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":27.35,"timestamp":1774641600000,"preClose":27.39,"halted":0,"volume":82907,"hourTrading":{"tag":"盘后","latestPrice":27.35,"preClose":27.35,"latestTime":"17:13 EDT","volume":544,"amount":14878.4,"timestamp":1774645985271,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.001460387002555646,"floatShares":33905700,"shares":64959500,"eps":-3.402257,"marketStatus":"Not Yet Opened","change":-0.04,"latestTime":"03-27 16:00:00 EDT","open":27.44,"high":27.91,"low":26.94,"amount":2268649.1571810003,"amplitude":0.035414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.402257,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":0,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":27.39,"preHourTrading":{"tag":"盘前","latestPrice":27.3,"preClose":27.39,"latestTime":"09:28 EDT","volume":1085,"amount":29716.80026,"timestamp":1774618080071,"change":-0.09,"changeRate":-0.003286,"amplitude":0.003286},"postHourTrading":{"tag":"盘后","latestPrice":27.35,"preClose":27.35,"latestTime":"17:13 EDT","volume":544,"amount":14878.4,"timestamp":1774645985271,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.40992222088526126,"impliedVol":0.4068,"impliedVolPercentile":0.3208},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","floatShares":33905700,"roa":"-32.07%","roe":"-53.76%","lyrEps":-2.572355,"volumeRatio":0.40992222088526126,"shares":64959500,"dividePrice":0,"high":27.91,"amplitude":0.035414,"preClose":27.39,"low":26.94,"week52Low":11.51,"pbRate":"4.94","week52High":29.797,"institutionHeld":0,"latestPrice":27.35,"eps":-3.402257,"divideRate":0,"volume":82907,"delay":0,"ttmEps":-3.402257,"open":27.44,"prevYearClose":27.75,"prevWeekClose":26,"prevMonthClose":28.39,"prevQuarterClose":27.75,"fiveDayClose":26,"twentyDayClose":28.39,"sixtyDayClose":26.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"PHVS","fiscalQuarterEnding":"2025/09","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-08-12","symbol":"PHVS","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.94},{"market":"US","date":"2025-05-13","symbol":"PHVS","fiscalQuarterEnding":"2025/03","expectedEps":-0.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2025-04-07","symbol":"PHVS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-11-13","symbol":"PHVS","fiscalQuarterEnding":"2024/09","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHVS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.3846,"hold":0.1538,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3846,"analysts":13,"updateTime":1773115200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHVS","date":"2026-03-27","current":-8.038781,"percent":0.401148,"low":-43.301145,"twenty":-12.835328,"median":-8.637068,"eighty":-5.918058,"high":-1.271834,"avg":-9.787637,"sd":5.641188,"marketCap":1779239445},"quantilePoints":[{"date":"2021-04-01","current":-41.621102,"twenty":-50.984249,"median":-43.918021,"eighty":-39.727138,"marketCap":924595810},{"date":"2021-04-09","current":-41.75527,"twenty":-50.647351,"median":-43.315034,"eighty":-39.727138,"marketCap":936835540},{"date":"2021-04-16","current":-40.837748,"twenty":-50.494041,"median":-42.658519,"eighty":-39.747341,"marketCap":923603399},{"date":"2021-04-23","current":-37.900499,"twenty":-49.17553,"median":-42.026105,"eighty":-38.829918,"marketCap":863066357},{"date":"2021-04-30","current":-25.541319,"twenty":-48.948372,"median":-41.646601,"eighty":-37.900499,"marketCap":798399091},{"date":"2021-05-07","current":-23.738176,"twenty":-48.895342,"median":-41.104912,"eighty":-36.326921,"marketCap":749700059},{"date":"2021-05-14","current":-22.435939,"twenty":-48.511867,"median":-40.837748,"eighty":-33.58931,"marketCap":707626746},{"date":"2021-05-21","current":-21.234553,"twenty":-47.818543,"median":-40.295032,"eighty":-26.156611,"marketCap":672510437},{"date":"2021-05-28","current":-19.380576,"twenty":-45.432957,"median":-39.747341,"eighty":-24.421758,"marketCap":679136156},{"date":"2021-06-04","current":-19.347354,"twenty":-45.352077,"median":-38.967887,"eighty":-23.463638,"marketCap":676817154},{"date":"2021-06-11","current":-19.412718,"twenty":-44.982641,"median":-38.721678,"eighty":-21.843417,"marketCap":675160725},{"date":"2021-06-18","current":-18.174436,"twenty":-44.643123,"median":-38.260176,"eighty":-21.113619,"marketCap":619504689},{"date":"2021-06-25","current":-17.828602,"twenty":-44.050431,"median":-37.439407,"eighty":-19.442186,"marketCap":612216398},{"date":"2021-07-02","current":-15.85879,"twenty":-43.775706,"median":-36.326921,"eighty":-19.370104,"marketCap":539996065},{"date":"2021-07-09","current":-14.490358,"twenty":-43.489807,"median":-35.672294,"eighty":-19.194795,"marketCap":494278607},{"date":"2021-07-16","current":-13.876053,"twenty":-43.313455,"median":-30.292192,"eighty":-19.061523,"marketCap":471088592},{"date":"2021-07-23","current":-14.202744,"twenty":-43.303543,"median":-26.3148,"eighty":-18.384979,"marketCap":480364598},{"date":"2021-07-30","current":-12.988167,"twenty":-42.915569,"median":-25.765358,"eighty":-18.050979,"marketCap":588695097},{"date":"2021-08-06","current":-11.844555,"twenty":-42.476534,"median":-24.421758,"eighty":-16.85205,"marketCap":532376489},{"date":"2021-08-13","current":-12.144906,"twenty":-42.312174,"median":-23.50716,"eighty":-15.514047,"marketCap":547615642},{"date":"2021-08-20","current":-12.372065,"twenty":-41.974629,"median":-22.435939,"eighty":-14.676752,"marketCap":552253645},{"date":"2021-08-27","current":-14.6624,"twenty":-41.760653,"median":-21.796739,"eighty":-14.375312,"marketCap":660584144},{"date":"2021-09-03","current":-13.869765,"twenty":-41.690069,"median":-21.159134,"eighty":-14.206363,"marketCap":629774552},{"date":"2021-09-10","current":-14.483783,"twenty":-41.636401,"median":-21.097683,"eighty":-14.200739,"marketCap":654620997},{"date":"2021-09-17","current":-13.408551,"twenty":-41.415194,"median":-19.619941,"eighty":-14.095163,"marketCap":601399913},{"date":"2021-09-24","current":-13.735189,"twenty":-41.105195,"median":-19.412718,"eighty":-13.917369,"marketCap":614535400},{"date":"2021-10-01","current":-13.275187,"twenty":-41.073352,"median":-19.361573,"eighty":-13.752501,"marketCap":588032525},{"date":"2021-10-08","current":-11.567624,"twenty":-40.951984,"median":-19.206349,"eighty":-13.609193,"marketCap":511505475},{"date":"2021-10-15","current":-11.808567,"twenty":-40.76486,"median":-19.158657,"eighty":-13.358075,"marketCap":523431769},{"date":"2021-10-22","current":-11.367098,"twenty":-40.543106,"median":-18.996962,"eighty":-13.26419,"marketCap":505211043},{"date":"2021-10-29","current":-13.069107,"twenty":-40.31092,"median":-18.615071,"eighty":-13.235325,"marketCap":577431375},{"date":"2021-11-05","current":-11.318661,"twenty":-40.118706,"median":-18.174436,"eighty":-12.989342,"marketCap":499744825},{"date":"2021-11-12","current":-12.526544,"twenty":-39.882961,"median":-18.037659,"eighty":-12.809718,"marketCap":547946928},{"date":"2021-11-19","current":-11.924212,"twenty":-39.73926,"median":-17.467833,"eighty":-12.433857,"marketCap":515812193},{"date":"2021-11-26","current":-10.362749,"twenty":-39.575288,"median":-16.707882,"eighty":-12.294384,"marketCap":448064220},{"date":"2021-12-03","current":-11.26034,"twenty":-38.958466,"median":-15.822297,"eighty":-12.166304,"marketCap":485665173},{"date":"2021-12-10","current":-11.449501,"twenty":-38.90261,"median":-15.106412,"eighty":-12.085176,"marketCap":494941179},{"date":"2021-12-17","current":-11.918983,"twenty":-38.786622,"median":-14.824901,"eighty":-12.032102,"marketCap":513493191},{"date":"2021-12-23","current":-12.067526,"twenty":-38.613439,"median":-14.809703,"eighty":-12.04158,"marketCap":521775339},{"date":"2021-12-31","current":-10.970608,"twenty":-38.556139,"median":-14.6624,"eighty":-12.029733,"marketCap":476720453},{"date":"2022-01-07","current":-14.755715,"twenty":-38.260176,"median":-14.556631,"eighty":-12.04158,"marketCap":639381844},{"date":"2022-01-14","current":-13.648303,"twenty":-37.900499,"median":-14.301086,"eighty":-12.059144,"marketCap":595652102},{"date":"2022-01-21","current":-13.462107,"twenty":-37.887735,"median":-14.301086,"eighty":-12.06585,"marketCap":583394522},{"date":"2022-01-28","current":-13.205088,"twenty":-37.172324,"median":-14.201073,"eighty":-12.067932,"marketCap":563186081},{"date":"2022-02-04","current":-13.024782,"twenty":-36.626254,"median":-14.120681,"eighty":-12.079807,"marketCap":569480513},{"date":"2022-02-11","current":-13.759795,"twenty":-36.368387,"median":-14.065459,"eighty":-12.092451,"marketCap":599627533},{"date":"2022-02-18","current":-13.388638,"twenty":-36.150333,"median":-14.023379,"eighty":-12.098608,"marketCap":579750377},{"date":"2022-02-25","current":-13.305926,"twenty":-35.845851,"median":-13.954525,"eighty":-12.116084,"marketCap":572793372},{"date":"2022-03-04","current":-14.115965,"twenty":-35.670778,"median":-13.938377,"eighty":-12.137788,"marketCap":588695097},{"date":"2022-03-11","current":-13.463028,"twenty":-34.421493,"median":-13.892451,"eighty":-12.149516,"marketCap":563186081},{"date":"2022-03-18","current":-14.218002,"twenty":-29.632768,"median":-13.881977,"eighty":-12.157248,"marketCap":600952677},{"date":"2022-03-25","current":-13.943073,"twenty":-26.658074,"median":-13.883771,"eighty":-12.178203,"marketCap":585382238},{"date":"2022-04-01","current":-12.747151,"twenty":-26.362243,"median":-13.880091,"eighty":-12.194172,"marketCap":601209361},{"date":"2022-04-08","current":-13.160374,"twenty":-26.219887,"median":-13.869765,"eighty":-12.198767,"marketCap":611652204},{"date":"2022-04-14","current":-12.64181,"twenty":-26.010325,"median":-13.786628,"eighty":-12.200601,"marketCap":583804624},{"date":"2022-04-22","current":-12.23556,"twenty":-25.770465,"median":-13.764494,"eighty":-12.203958,"marketCap":563581977},{"date":"2022-04-29","current":-12.580911,"twenty":-25.660418,"median":-13.730786,"eighty":-12.217679,"marketCap":566542439},{"date":"2022-05-06","current":-12.310085,"twenty":-25.093495,"median":-13.707219,"eighty":-12.233824,"marketCap":557283119},{"date":"2022-05-13","current":-10.422165,"twenty":-24.148325,"median":-13.655613,"eighty":-12.198139,"marketCap":571878572},{"date":"2022-05-20","current":-10.134271,"twenty":-23.650401,"median":-13.608097,"eighty":-12.152353,"marketCap":563590477},{"date":"2022-05-27","current":-10.266885,"twenty":-23.509475,"median":-13.570194,"eighty":-12.096742,"marketCap":579835143},{"date":"2022-06-03","current":-10.984203,"twenty":-23.463638,"median":-13.4682,"eighty":-12.07039,"marketCap":620612572},{"date":"2022-06-10","current":-12.843347,"twenty":-23.155882,"median":-13.459721,"eighty":-12.067627,"marketCap":712444667},{"date":"2022-06-17","current":-16.528573,"twenty":-22.410251,"median":-13.457335,"eighty":-12.07039,"marketCap":911690477},{"date":"2022-06-24","current":-12.484354,"twenty":-22.307498,"median":-13.442896,"eighty":-12.079819,"marketCap":694210858},{"date":"2022-07-01","current":-14.299351,"twenty":-21.874535,"median":-13.402807,"eighty":-12.068033,"marketCap":784053810},{"date":"2022-07-08","current":-14.094213,"twenty":-21.750061,"median":-13.450115,"eighty":-12.077462,"marketCap":756209125},{"date":"2022-07-15","current":-14.396825,"twenty":-21.331431,"median":-13.463028,"eighty":-12.082165,"marketCap":765820001},{"date":"2022-07-22","current":-13.29424,"twenty":-21.174218,"median":-13.473474,"eighty":-12.092451,"marketCap":716422953},{"date":"2022-07-29","current":-13.469033,"twenty":-21.125909,"median":-13.4682,"eighty":-12.098608,"marketCap":724213762},{"date":"2022-08-05","current":-11.76507,"twenty":-21.101667,"median":-13.459721,"eighty":-12.082165,"marketCap":629895239},{"date":"2022-08-12","current":-10.43948,"twenty":-20.186916,"median":-13.408551,"eighty":-12.055631,"marketCap":564253524},{"date":"2022-08-19","current":-11.581834,"twenty":-19.826532,"median":-13.395996,"eighty":-12.028713,"marketCap":612987524},{"date":"2022-08-26","current":-5.820227,"twenty":-19.515891,"median":-13.372919,"eighty":-11.990749,"marketCap":306659524},{"date":"2022-09-02","current":-5.892736,"twenty":-19.429171,"median":-13.356682,"eighty":-11.943475,"marketCap":311632381},{"date":"2022-09-09","current":-5.834763,"twenty":-19.417564,"median":-13.345814,"eighty":-11.915113,"marketCap":308814429},{"date":"2022-09-16","current":-6.129031,"twenty":-19.393433,"median":-13.317212,"eighty":-11.844209,"marketCap":307945619},{"date":"2022-09-23","current":-5.527907,"twenty":-19.377706,"median":-13.304479,"eighty":-11.805952,"marketCap":269452416},{"date":"2022-09-30","current":-5.268219,"twenty":-19.358729,"median":-13.29424,"eighty":-11.739355,"marketCap":258984966},{"date":"2022-10-07","current":-3.334511,"twenty":-19.313349,"median":-13.281408,"eighty":-11.574558,"marketCap":163427280},{"date":"2022-10-14","current":-3.192899,"twenty":-19.240081,"median":-13.26552,"eighty":-11.519941,"marketCap":155998767},{"date":"2022-10-21","current":-3.776992,"twenty":-19.189017,"median":-13.2607,"eighty":-11.419826,"marketCap":185712818},{"date":"2022-10-28","current":-3.404363,"twenty":-19.175941,"median":-13.241782,"eighty":-11.34035,"marketCap":169704373},{"date":"2022-11-04","current":-2.493588,"twenty":-19.155403,"median":-13.21909,"eighty":-11.293284,"marketCap":123921098},{"date":"2022-11-11","current":-1.962841,"twenty":-19.119693,"median":-13.202703,"eighty":-11.220822,"marketCap":101635560},{"date":"2022-11-18","current":-1.709372,"twenty":-19.040002,"median":-13.169144,"eighty":-11.073401,"marketCap":88804493},{"date":"2022-11-25","current":-1.59989,"twenty":-18.960552,"median":-13.089194,"eighty":-10.924331,"marketCap":83401938},{"date":"2022-12-02","current":-1.271834,"twenty":-18.879299,"median":-13.066255,"eighty":-10.549888,"marketCap":66856614},{"date":"2022-12-09","current":-5.585763,"twenty":-18.659925,"median":-13.055482,"eighty":-10.38824,"marketCap":291250318},{"date":"2022-12-16","current":-4.830297,"twenty":-18.384979,"median":-13.024782,"eighty":-10.32247,"marketCap":253408050},{"date":"2022-12-23","current":-6.371604,"twenty":-18.295522,"median":-12.990589,"eighty":-10.187317,"marketCap":334836503},{"date":"2022-12-30","current":-7.188594,"twenty":-18.170479,"median":-12.982972,"eighty":-10.008759,"marketCap":380112075},{"date":"2023-01-06","current":-7.688928,"twenty":-18.154652,"median":-12.903124,"eighty":-9.752954,"marketCap":403763493},{"date":"2023-01-13","current":-5.706058,"twenty":-18.104257,"median":-12.846213,"eighty":-7.688928,"marketCap":305441169},{"date":"2023-01-20","current":-6.459312,"twenty":-17.9977,"median":-12.837332,"eighty":-7.374204,"marketCap":346324335},{"date":"2023-01-27","current":-5.951135,"twenty":-17.857094,"median":-12.821298,"eighty":-6.862976,"marketCap":319632020},{"date":"2023-02-03","current":-5.776873,"twenty":-17.539987,"median":-12.756949,"eighty":-6.367933,"marketCap":310171453},{"date":"2023-02-10","current":-6.06212,"twenty":-17.052096,"median":-12.693639,"eighty":-6.243368,"marketCap":320307775},{"date":"2023-02-17","current":-5.565251,"twenty":-16.755938,"median":-12.64181,"eighty":-6.151395,"marketCap":293615460},{"date":"2023-02-24","current":-5.080906,"twenty":-16.600297,"median":-12.612561,"eighty":-6.08797,"marketCap":265233759},{"date":"2023-03-03","current":-5.604926,"twenty":-16.439572,"median":-12.581052,"eighty":-6.019199,"marketCap":293953338},{"date":"2023-03-10","current":-4.059398,"twenty":-16.126823,"median":-12.554737,"eighty":-5.957727,"marketCap":214214271},{"date":"2023-03-17","current":-4.759844,"twenty":-15.898426,"median":-12.5386,"eighty":-5.915214,"marketCap":251042908},{"date":"2023-03-24","current":-4.748457,"twenty":-15.814998,"median":-12.484354,"eighty":-5.839251,"marketCap":252732295},{"date":"2023-03-31","current":-5.062872,"twenty":-15.558556,"median":-12.41617,"eighty":-5.818726,"marketCap":272160245},{"date":"2023-04-06","current":-5.515395,"twenty":-15.2868,"median":-12.393076,"eighty":-5.798276,"marketCap":298007866},{"date":"2023-04-14","current":-3.407139,"twenty":-15.104598,"median":-12.376683,"eighty":-5.751686,"marketCap":287439901},{"date":"2023-04-21","current":-3.423024,"twenty":-15.075219,"median":-12.365371,"eighty":-5.695738,"marketCap":286594490},{"date":"2023-04-28","current":-3.621546,"twenty":-14.971826,"median":-12.310085,"eighty":-5.661512,"marketCap":304686295},{"date":"2023-05-05","current":-3.635585,"twenty":-14.858222,"median":-12.26867,"eighty":-5.593428,"marketCap":305362624},{"date":"2023-05-12","current":-3.330904,"twenty":-14.826016,"median":-12.249364,"eighty":-5.568587,"marketCap":277633128},{"date":"2023-05-19","current":-3.332274,"twenty":-14.818952,"median":-12.234113,"eighty":-5.5204,"marketCap":297584839},{"date":"2023-05-26","current":-3.231497,"twenty":-14.811441,"median":-12.222059,"eighty":-5.439393,"marketCap":287439901},{"date":"2023-06-02","current":-3.434585,"twenty":-14.791955,"median":-12.201472,"eighty":-5.312927,"marketCap":305832502},{"date":"2023-06-09","current":-3.407273,"twenty":-14.764775,"median":-12.198453,"eighty":-5.28475,"marketCap":304479261},{"date":"2023-06-16","current":-4.170938,"twenty":-14.740265,"median":-12.160354,"eighty":-5.07843,"marketCap":377892593},{"date":"2023-06-23","current":-4.359744,"twenty":-14.731325,"median":-12.152393,"eighty":-5.057591,"marketCap":396297439},{"date":"2023-06-30","current":-7.00064,"twenty":-14.718305,"median":-12.136009,"eighty":-5.055831,"marketCap":632126719},{"date":"2023-07-07","current":-7.084548,"twenty":-14.696694,"median":-12.097209,"eighty":-5.062872,"marketCap":638244074},{"date":"2023-07-14","current":-6.875228,"twenty":-14.6624,"median":-12.079819,"eighty":-5.068525,"marketCap":638244074},{"date":"2023-07-21","current":-7.028003,"twenty":-14.653302,"median":-12.064139,"eighty":-5.080906,"marketCap":649663138},{"date":"2023-07-28","current":-7.498848,"twenty":-14.622905,"median":-12.04158,"eighty":-5.207419,"marketCap":683512504},{"date":"2023-08-04","current":-7.953511,"twenty":-14.601036,"median":-12.024634,"eighty":-5.228713,"marketCap":722255754},{"date":"2023-08-11","current":-7.354477,"twenty":-14.583407,"median":-11.998532,"eighty":-5.261383,"marketCap":747059362},{"date":"2023-08-18","current":-7.862758,"twenty":-14.572779,"median":-11.956319,"eighty":-5.28475,"marketCap":788698737},{"date":"2023-08-25","current":-7.637624,"twenty":-14.506463,"median":-11.943194,"eighty":-5.298861,"marketCap":762796904},{"date":"2023-08-31","current":-8.133422,"twenty":-14.4867,"median":-11.921598,"eighty":-5.305964,"marketCap":813459365},{"date":"2023-09-08","current":-7.866907,"twenty":-14.484166,"median":-11.909309,"eighty":-5.312927,"marketCap":776279656},{"date":"2023-09-15","current":-8.565073,"twenty":-14.483879,"median":-11.869315,"eighty":-5.324599,"marketCap":842467710},{"date":"2023-09-22","current":-8.218785,"twenty":-14.422991,"median":-11.843691,"eighty":-5.364732,"marketCap":808147978},{"date":"2023-09-29","current":-8.499622,"twenty":-14.407261,"median":-11.810464,"eighty":-5.391254,"marketCap":828167822},{"date":"2023-10-06","current":-8.075664,"twenty":-14.404891,"median":-11.805298,"eighty":-5.421144,"marketCap":784042452},{"date":"2023-10-13","current":-7.97887,"twenty":-14.393189,"median":-11.762441,"eighty":-5.494747,"marketCap":776279656},{"date":"2023-10-20","current":-7.871535,"twenty":-14.374592,"median":-11.67635,"eighty":-5.497417,"marketCap":767699722},{"date":"2023-10-27","current":-7.699507,"twenty":-14.37054,"median":-11.628617,"eighty":-5.497654,"marketCap":747679879},{"date":"2023-11-03","current":-7.17043,"twenty":-14.351862,"median":-11.573402,"eighty":-5.505177,"marketCap":701920236},{"date":"2023-11-10","current":-5.970942,"twenty":-14.325681,"median":-11.546094,"eighty":-5.518658,"marketCap":686476556},{"date":"2023-11-17","current":-5.487665,"twenty":-14.300392,"median":-11.499199,"eighty":-5.518658,"marketCap":639755166},{"date":"2023-11-24","current":-5.931936,"twenty":-14.283081,"median":-11.456561,"eighty":-5.501771,"marketCap":694263454},{"date":"2023-12-01","current":-6.025826,"twenty":-14.216157,"median":-11.367098,"eighty":-5.517027,"marketCap":705329046},{"date":"2023-12-08","current":-11.439876,"twenty":-14.20757,"median":-11.347894,"eighty":-5.524424,"marketCap":1324602518},{"date":"2023-12-15","current":-11.41059,"twenty":-14.202076,"median":-11.375314,"eighty":-5.532271,"marketCap":1346488162},{"date":"2023-12-22","current":-11.925452,"twenty":-14.184853,"median":-11.42744,"eighty":-5.551316,"marketCap":1406934225},{"date":"2023-12-29","current":-12.247032,"twenty":-14.141201,"median":-11.449501,"eighty":-5.556079,"marketCap":1455916379},{"date":"2024-01-05","current":-11.217845,"twenty":-14.124263,"median":-11.444688,"eighty":-5.560701,"marketCap":1319391651},{"date":"2024-01-12","current":-13.194311,"twenty":-14.118795,"median":-11.460366,"eighty":-5.568587,"marketCap":1550325393},{"date":"2024-01-19","current":-14.465426,"twenty":-14.174814,"median":-11.47464,"eighty":-5.574125,"marketCap":1686754028},{"date":"2024-01-26","current":-14.983944,"twenty":-14.20757,"median":-11.499199,"eighty":-5.577066,"marketCap":1742861042},{"date":"2024-02-02","current":-15.192524,"twenty":-14.300739,"median":-11.528223,"eighty":-5.581389,"marketCap":1768847449},{"date":"2024-02-09","current":-14.748842,"twenty":-14.393189,"median":-11.54682,"eighty":-5.589596,"marketCap":1703881432},{"date":"2024-02-16","current":-13.65194,"twenty":-14.404891,"median":-11.567624,"eighty":-5.608959,"marketCap":1576311800},{"date":"2024-02-23","current":-14.13304,"twenty":-14.396825,"median":-11.581834,"eighty":-5.625092,"marketCap":1640687216},{"date":"2024-03-01","current":-10.303743,"twenty":-14.378644,"median":-11.573402,"eighty":-5.629721,"marketCap":1195373004},{"date":"2024-03-08","current":-12.093153,"twenty":-14.358385,"median":-11.567624,"eighty":-5.636181,"marketCap":1418455194},{"date":"2024-03-15","current":-10.896325,"twenty":-14.342077,"median":-11.552539,"eighty":-5.658684,"marketCap":1273758779},{"date":"2024-03-22","current":-11.538805,"twenty":-14.301086,"median":-11.546205,"eighty":-5.665753,"marketCap":1344762225},{"date":"2024-03-28","current":-10.904189,"twenty":-14.299698,"median":-11.538805,"eighty":-5.674035,"marketCap":1264076491},{"date":"2024-04-05","current":-10.349243,"twenty":-14.288877,"median":-11.507756,"eighty":-5.680711,"marketCap":1206520668},{"date":"2024-04-12","current":-11.107813,"twenty":-14.231653,"median":-11.490879,"eighty":-5.687459,"marketCap":1200065809},{"date":"2024-04-19","current":-9.215802,"twenty":-14.210621,"median":-11.46913,"eighty":-5.702618,"marketCap":991303742},{"date":"2024-04-26","current":-11.339937,"twenty":-14.20395,"median":-11.459096,"eighty":-5.715476,"marketCap":1225406418},{"date":"2024-05-03","current":-11.733497,"twenty":-14.200071,"median":-11.46913,"eighty":-5.724599,"marketCap":1266307115},{"date":"2024-05-10","current":-9.668623,"twenty":-14.189365,"median":-11.459096,"eighty":-5.733174,"marketCap":1107009662},{"date":"2024-05-17","current":-10.115404,"twenty":-14.156013,"median":-11.42744,"eighty":-5.759289,"marketCap":1168360708},{"date":"2024-05-24","current":-9.147602,"twenty":-14.136092,"median":-11.375314,"eighty":-5.774576,"marketCap":1052116621},{"date":"2024-05-31","current":-8.827191,"twenty":-14.129207,"median":-11.35501,"eighty":-5.782121,"marketCap":1017135762},{"date":"2024-06-07","current":-7.823819,"twenty":-14.123069,"median":-11.339823,"eighty":-5.787829,"marketCap":904658844},{"date":"2024-06-14","current":-8.515887,"twenty":-14.119026,"median":-11.316994,"eighty":-5.792437,"marketCap":974082396},{"date":"2024-06-21","current":-8.52603,"twenty":-14.116428,"median":-11.288753,"eighty":-5.797709,"marketCap":970853394},{"date":"2024-06-28","current":-8.52006,"twenty":-14.116197,"median":-11.262481,"eighty":-5.798843,"marketCap":969238893},{"date":"2024-07-05","current":-7.963908,"twenty":-14.11303,"median":-11.251924,"eighty":-5.805313,"marketCap":914884019},{"date":"2024-07-12","current":-8.497692,"twenty":-14.104041,"median":-11.224936,"eighty":-5.814579,"marketCap":981616735},{"date":"2024-07-15","current":-8.709438,"twenty":-14.101747,"median":-11.224715,"eighty":-5.815211,"marketCap":1010139590},{"date":"2024-08-02","current":-7.485095,"twenty":-14.099454,"median":-11.224493,"eighty":-5.815842,"marketCap":857838309},{"date":"2024-08-09","current":-7.640912,"twenty":-14.094802,"median":-11.205504,"eighty":-5.819476,"marketCap":885822997},{"date":"2024-08-16","current":-8.240501,"twenty":-14.093907,"median":-11.162588,"eighty":-5.823431,"marketCap":1032742607},{"date":"2024-08-23","current":-7.760367,"twenty":-14.048436,"median":-11.118035,"eighty":-5.826337,"marketCap":983480417},{"date":"2024-08-30","current":-7.393035,"twenty":-14.034683,"median":-11.087899,"eighty":-5.833183,"marketCap":934333400},{"date":"2024-09-06","current":-8.155019,"twenty":-14.033224,"median":-11.020127,"eighty":-5.839251,"marketCap":1031547280},{"date":"2024-09-13","current":-8.802104,"twenty":-14.027088,"median":-10.978779,"eighty":-5.849019,"marketCap":1108238229},{"date":"2024-09-20","current":-8.962749,"twenty":-13.99324,"median":-10.957045,"eighty":-5.877056,"marketCap":1139022624},{"date":"2024-09-27","current":-8.000083,"twenty":-13.961974,"median":-10.894902,"eighty":-5.894802,"marketCap":1020205660},{"date":"2024-10-04","current":-7.688355,"twenty":-13.947654,"median":-10.874176,"eighty":-5.909483,"marketCap":966197949},{"date":"2024-10-11","current":-7.725025,"twenty":-13.936046,"median":-10.812773,"eighty":-5.924083,"marketCap":962957487},{"date":"2024-10-18","current":-9.289256,"twenty":-13.925882,"median":-10.792815,"eighty":-5.928401,"marketCap":1147663858},{"date":"2024-10-25","current":-9.347449,"twenty":-13.904362,"median":-10.773913,"eighty":-5.930655,"marketCap":1151984475},{"date":"2024-10-31","current":-10.81176,"twenty":-13.888979,"median":-10.69668,"eighty":-5.935928,"marketCap":1339391232},{"date":"2024-11-08","current":-9.795031,"twenty":-13.882336,"median":-10.614452,"eighty":-5.945603,"marketCap":1205452109},{"date":"2024-11-15","current":-7.934741,"twenty":-13.880109,"median":-10.567811,"eighty":-5.951569,"marketCap":1109858461},{"date":"2024-11-22","current":-8.193559,"twenty":-13.878421,"median":-10.530141,"eighty":-5.955891,"marketCap":1136322239},{"date":"2024-11-29","current":-8.515548,"twenty":-13.874795,"median":-10.499116,"eighty":-5.962822,"marketCap":1187704999},{"date":"2024-12-06","current":-7.575701,"twenty":-13.869107,"median":-10.430822,"eighty":-5.969,"marketCap":1058630209},{"date":"2024-12-13","current":-7.438607,"twenty":-13.864864,"median":-10.405945,"eighty":-5.972,"marketCap":1031513657},{"date":"2024-12-20","current":-7.511117,"twenty":-13.847086,"median":-10.370165,"eighty":-5.976517,"marketCap":1030971326},{"date":"2024-12-27","current":-7.680726,"twenty":-13.801742,"median":-10.357252,"eighty":-5.977661,"marketCap":1057545547},{"date":"2025-01-03","current":-7.415916,"twenty":-13.792864,"median":-10.345951,"eighty":-6.00833,"marketCap":1005481766},{"date":"2025-01-10","current":-7.387777,"twenty":-13.788234,"median":-10.323543,"eighty":-6.019199,"marketCap":1005481766},{"date":"2025-01-17","current":-6.953437,"twenty":-13.781733,"median":-10.297117,"eighty":-6.023626,"marketCap":946367682},{"date":"2025-01-24","current":-7.612205,"twenty":-13.774759,"median":-10.284647,"eighty":-6.025423,"marketCap":1047783588},{"date":"2025-01-31","current":-6.977006,"twenty":-13.765434,"median":-10.25901,"eighty":-6.034301,"marketCap":961552951},{"date":"2025-02-07","current":-7.219276,"twenty":-13.753463,"median":-10.232674,"eighty":-6.052543,"marketCap":990296497},{"date":"2025-02-14","current":-6.822516,"twenty":-13.740454,"median":-10.115609,"eighty":-6.061351,"marketCap":942029033},{"date":"2025-02-21","current":-6.467941,"twenty":-13.734308,"median":-10.093087,"eighty":-6.062421,"marketCap":894846232},{"date":"2025-02-28","current":-6.133931,"twenty":-13.727465,"median":-10.02417,"eighty":-6.065143,"marketCap":843867113},{"date":"2025-03-07","current":-5.852269,"twenty":-13.71316,"median":-9.970579,"eighty":-6.049778,"marketCap":837901472},{"date":"2025-03-14","current":-6.385184,"twenty":-13.708332,"median":-9.910974,"eighty":-6.026825,"marketCap":917081805},{"date":"2025-03-21","current":-5.844642,"twenty":-13.700767,"median":-9.829627,"eighty":-6.025288,"marketCap":838443803},{"date":"2025-03-28","current":-5.916884,"twenty":-13.679442,"median":-9.795031,"eighty":-5.984934,"marketCap":844409444},{"date":"2025-04-04","current":-5.41793,"twenty":-13.665275,"median":-9.712775,"eighty":-5.969,"marketCap":792887995},{"date":"2025-04-11","current":-4.319691,"twenty":-13.654878,"median":-9.636637,"eighty":-5.953745,"marketCap":648468389},{"date":"2025-04-17","current":-4.898467,"twenty":-13.65194,"median":-9.603412,"eighty":-5.931936,"marketCap":747645908},{"date":"2025-04-25","current":-5.660159,"twenty":-13.648303,"median":-9.484661,"eighty":-5.916884,"marketCap":862626437},{"date":"2025-05-02","current":-6.426634,"twenty":-13.611466,"median":-9.396394,"eighty":-5.918352,"marketCap":972702584},{"date":"2025-05-09","current":-6.135697,"twenty":-13.604729,"median":-9.345786,"eighty":-5.927903,"marketCap":928563139},{"date":"2025-05-16","current":-5.081075,"twenty":-13.598948,"median":-9.280564,"eighty":-5.916884,"marketCap":866985889},{"date":"2025-05-23","current":-5.189286,"twenty":-13.570194,"median":-9.208581,"eighty":-5.882056,"marketCap":893142597},{"date":"2025-05-30","current":-5.256736,"twenty":-13.527456,"median":-9.173722,"eighty":-5.851134,"marketCap":911125334},{"date":"2025-06-06","current":-5.007101,"twenty":-13.509055,"median":-9.060878,"eighty":-5.837961,"marketCap":874614929},{"date":"2025-06-13","current":-5.317982,"twenty":-13.49872,"median":-8.982791,"eighty":-5.819476,"marketCap":938916836},{"date":"2025-06-20","current":-5.183436,"twenty":-13.485895,"median":-8.943559,"eighty":-5.800161,"marketCap":906765882},{"date":"2025-06-27","current":-5.465947,"twenty":-13.472919,"median":-8.879507,"eighty":-5.782121,"marketCap":975427241},{"date":"2025-07-03","current":-5.649134,"twenty":-13.4687,"median":-8.851321,"eighty":-5.729733,"marketCap":1013572441},{"date":"2025-07-11","current":-6.060959,"twenty":-13.466131,"median":-8.823918,"eighty":-5.695738,"marketCap":1080599005},{"date":"2025-07-18","current":-7.314861,"twenty":-13.46266,"median":-8.816193,"eighty":-5.710767,"marketCap":1293122259},{"date":"2025-07-25","current":-7.006501,"twenty":-13.460198,"median":-8.785147,"eighty":-5.721214,"marketCap":1257999997},{"date":"2025-08-01","current":-8.237689,"twenty":-13.451559,"median":-8.722056,"eighty":-5.729733,"marketCap":1437436162},{"date":"2025-08-08","current":-8.281316,"twenty":-13.442628,"median":-8.688191,"eighty":-5.747092,"marketCap":1469250645},{"date":"2025-08-15","current":-8.47781,"twenty":-13.428755,"median":-8.660023,"eighty":-5.769982,"marketCap":1662306709},{"date":"2025-08-22","current":-8.638654,"twenty":-13.403956,"median":-8.63053,"eighty":-5.780372,"marketCap":1688336740},{"date":"2025-08-29","current":-8.414646,"twenty":-13.396944,"median":-8.638654,"eighty":-5.787092,"marketCap":1651460863},{"date":"2025-09-05","current":-8.112917,"twenty":-13.396458,"median":-8.622065,"eighty":-5.790869,"marketCap":1589278011},{"date":"2025-09-12","current":-8.597222,"twenty":-13.393909,"median":-8.60362,"eighty":-5.797709,"marketCap":1699182587},{"date":"2025-09-19","current":-8.94501,"twenty":-13.385494,"median":-8.610019,"eighty":-5.800038,"marketCap":1774380454},{"date":"2025-09-26","current":-9.045131,"twenty":-13.370479,"median":-8.627645,"eighty":-5.80289,"marketCap":1777272680},{"date":"2025-10-03","current":-8.512022,"twenty":-13.360301,"median":-8.638654,"eighty":-5.813948,"marketCap":1676044781},{"date":"2025-10-10","current":-8.486281,"twenty":-13.357847,"median":-8.622235,"eighty":-5.817225,"marketCap":1651460863},{"date":"2025-10-17","current":-8.047023,"twenty":-13.353429,"median":-8.597222,"eighty":-5.821028,"marketCap":1580601334},{"date":"2025-10-24","current":-8.513119,"twenty":-13.347233,"median":-8.60362,"eighty":-5.824758,"marketCap":1663029766},{"date":"2025-10-31","current":-8.263348,"twenty":-13.342738,"median":-8.57038,"eighty":-5.828443,"marketCap":1608077478},{"date":"2025-11-07","current":-8.118597,"twenty":-13.33536,"median":-8.561701,"eighty":-5.835563,"marketCap":1576262995},{"date":"2025-11-14","current":-8.953433,"twenty":-13.315064,"median":-8.562935,"eighty":-5.839457,"marketCap":1754134874},{"date":"2025-11-21","current":-8.32101,"twenty":-13.306363,"median":-8.564004,"eighty":-5.842723,"marketCap":1572018786},{"date":"2025-11-28","current":-9.70873,"twenty":-13.305926,"median":-8.567726,"eighty":-5.844642,"marketCap":1843549304},{"date":"2025-12-05","current":-9.421046,"twenty":-13.303031,"median":-8.581097,"eighty":-5.846596,"marketCap":1798727281},{"date":"2025-12-12","current":-8.095034,"twenty":-13.295471,"median":-8.575738,"eighty":-5.852269,"marketCap":1557727706},{"date":"2025-12-19","current":-8.116161,"twenty":-13.29424,"median":-8.562935,"eighty":-5.853536,"marketCap":1560326085},{"date":"2025-12-26","current":-8.732727,"twenty":-13.291734,"median":-8.57038,"eighty":-5.866198,"marketCap":1684398642},{"date":"2026-01-02","current":-9.374295,"twenty":-13.28902,"median":-8.597222,"eighty":-5.876979,"marketCap":1802624848},{"date":"2026-01-09","current":-8.51177,"twenty":-13.280164,"median":-8.575738,"eighty":-5.882433,"marketCap":1623986350},{"date":"2026-01-16","current":-8.766662,"twenty":-13.272619,"median":-8.610019,"eighty":-5.888715,"marketCap":1666209995},{"date":"2026-01-23","current":-9.448662,"twenty":-13.268752,"median":-8.622065,"eighty":-5.894114,"marketCap":1817565522},{"date":"2026-01-30","current":-9.241158,"twenty":-13.264633,"median":-8.634183,"eighty":-5.904462,"marketCap":1805223226},{"date":"2026-02-06","current":-8.459688,"twenty":-13.260074,"median":-8.637068,"eighty":-5.918058,"marketCap":1633080673},{"date":"2026-02-13","current":-8.89399,"twenty":-13.217763,"median":-8.637068,"eighty":-5.918058,"marketCap":1727921476},{"date":"2026-02-20","current":-9.442084,"twenty":-13.195802,"median":-8.637068,"eighty":-5.918058,"marketCap":1818864712},{"date":"2026-02-27","current":-9.418754,"twenty":-13.077142,"median":-8.637068,"eighty":-5.918058,"marketCap":1818864712},{"date":"2026-03-06","current":-8.866459,"twenty":-13.050618,"median":-8.637068,"eighty":-5.918058,"marketCap":1678552291},{"date":"2026-03-13","current":-9.080009,"twenty":-12.99028,"median":-8.637068,"eighty":-5.918058,"marketCap":1713630396},{"date":"2026-03-20","current":-8.989812,"twenty":-12.872607,"median":-8.637068,"eighty":-5.918058,"marketCap":1697390533},{"date":"2026-03-27","current":-9.422218,"twenty":-12.835328,"median":-8.637068,"eighty":-5.918058,"marketCap":1779239445}],"updateTime":1774844902567},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHVS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616832064","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pharvaris (PHVS) and Cryo-Cell International (CCEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616832064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616832064?lang=en_us&edition=fundamental","pubTime":"2026-03-04 01:00","pubTimestamp":1772557250,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pharvaris (PHVS – Research Report) and Cryo-Cell I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pharvaris-phvs-and-cryo-cell-international-ccel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pharvaris-phvs-and-cryo-cell-international-ccel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0029874061.USD","BK4137","LABU","BK4585","XBI","BK4196","CCEL","BK4581","BK4588","HCSG","PHVS","XLV","LU0128526141.USD"],"gpt_icon":0},{"id":"2616276263","title":"Pharvaris Price Target Maintained With a $60.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2616276263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616276263?lang=en_us&edition=fundamental","pubTime":"2026-03-04 00:58","pubTimestamp":1772557080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHVS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2026 11:58 ET (16:58 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2616329691","title":"Pharvaris (PHVS) Valuation Check After Positive Deucrictibant Phase 2 And RAPIDe 3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2616329691","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616329691?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:27","pubTimestamp":1772548065,"startTime":"0","endTime":"0","summary":"Pharvaris (NasdaqGS:PHVS) is back in focus after releasing final Phase 2 CHAPTER-1 open-label extension data and detailed RAPIDe-3 results for deucrictibant in hereditary angioedema, underscoring fresh clinical evidence around both prophylactic and on-demand use.\nSee our latest analysis for Pharvaris.\nThe latest deucrictibant data arrives after a powerful run in Pharvaris’ total shareholder return, with an 82.77% 1 year gain and a very large 3 year payoff. The recent 90 day share price return...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-valuation-check-after-positive-deucrictibant","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-valuation-check-after-positive-deucrictibant","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DCF","PHVS"],"gpt_icon":0},{"id":"2616833961","title":"Pharvaris reports Phase 3 RAPIDe-3 success for deucrictibant in hereditary angioedema attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2616833961","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616833961?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:50","pubTimestamp":1772452215,"startTime":"0","endTime":"0","summary":"Pharvaris NV announced clinical data for deucrictibant, an oral bradykinin B2 receptor antagonist being developed for hereditary angioedema , highlighting results from the Phase 3 placebo-controlled RAPIDe-3 study and final long-term findings from the Phase 2 CHAPTER-1 open-label extension. The company said these results were presented at the American Academy of Allergy, Asthma & Immunology  2026 Annual Meeting, including RAPIDe-3 outcomes showing a median 1.28 hours to onset of symptom relief and 11.95 hours to complete symptom resolution versus placebo, and CHAPTER-1 data reporting a reduction in mean attack rate from 2.18 attacks/month at baseline to 0.12 attacks/month during the extension. Pharvaris also presented Phase 1 pharmacokinetic data supporting once-daily dosing of an extended-release deucrictibant tablet for prophylaxis.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL1n8F9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","BK4588","NDAQ","PHVS","SG9999014005.SGD","LU0314104364.USD","SG9999014039.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2614877051","title":"BRAIN Biotech posts Q1 net loss of EUR 2.9 million, revenue down 9% to EUR 11.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614877051","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614877051?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:30","pubTimestamp":1772001047,"startTime":"0","endTime":"0","summary":"BRAIN Biotech reported Q1 FY 2025/26 revenue of EUR 11.9 million, down 9.0%, with total operating performance of EUR 13.0 million. Adjusted EBITDA was EUR 0.3 million, while EBITDA was EUR -0.3 million and EBIT was EUR -1.5 million. Net loss for the period was EUR 2.9 million, with EPS  of EUR -0.13. In BRAINBiocatalysts, Q1 revenue was EUR 10.0 million  and adjusted EBITDA was EUR 0.5 million, with the company citing low sales momentum in baking enzymes and production interruptions tied to the relocation of production facilities to a new joint site in the Netherlands. BRAINBioIncubator Q1 revenue was EUR 1.9 million, supported by a EUR 1.0 million milestone payment related to the deucrictibant project; the company also noted that license and monetization agreements with Pharvaris and Royalty Pharma have generated EUR 3.3 million in milestone payments so far in FY 2025/26, including EUR 2.3 million received as cash inflow in Q1. Cash and cash equivalents were EUR 5.1 million at 31 Dece","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL5DmRdQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS","RPRX"],"gpt_icon":0},{"id":"2612450601","title":"Morgan Stanley Remains a Buy on Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612450601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612450601?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:56","pubTimestamp":1771336606,"startTime":"0","endTime":"0","summary":"In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Pharvaris, with a price target of $41.00. According to TipR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2028103732.USD","LU2089284900.SGD","BK4007","BK4504","BK4516","LU2133065610.SGD","LU0528227936.USD","LU1244550577.SGD","LU2271345857.HKD","LU1989772840.SGD","LU1074936037.SGD","LU0795875169.SGD","LU1363072403.SGD","LU0912757837.SGD","BK4581","LU0971096721.USD","LU0098860793.USD","LU0267386448.USD","BK4585","LU1162221912.USD","LU0158827781.USD","IE00BZ1G4Q59.USD","BK4127","LU0314104364.USD","LU1791710582.SGD","LU1244550221.USD","LU0106261372.USD","LU1791710400.SGD","LU2089283258.USD","LU1668664300.SGD","BK4588","LU0158827948.USD","LU0225283273.USD","LU0557290698.USD","LU1548497426.USD","LU1732799900.SGD","BK4534","LU0006306889.USD","IE00BKVL7J92.USD","LU1989772923.USD","LU2347655156.SGD","LU0320765646.SGD","LU1720051017.SGD","LU0106831901.USD","LU0234570918.USD","LU1732800096.USD","PHVS","LU2357305700.SGD","LU0882574139.USD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2611185302","title":"A Look At Pharvaris (PHVS) Valuation As Deucrictibant Advances With New Phase 3 And Phase 2 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2611185302","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611185302?lang=en_us&edition=fundamental","pubTime":"2026-02-13 10:35","pubTimestamp":1770950140,"startTime":"0","endTime":"0","summary":"Investor takeaways from Pharvaris’s latest clinical milestone\nPharvaris (PHVS) is back in focus after announcing that six abstracts, including pivotal Phase 3 RAPIDe-3 data for deucrictibant in hereditary angioedema, have been accepted for presentation at the AAAAI 2026 Annual Meeting.\nSee our latest analysis for Pharvaris.\nThe latest clinical progress comes as Pharvaris’s share price sits at US$26.60, with a 7 day share price return of 5.81% and a 90 day share price return of 12.95%. The 1...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/a-look-at-pharvaris-phvs-valuation-as-deucrictibant-advances","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/a-look-at-pharvaris-phvs-valuation-as-deucrictibant-advances","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4007","PHVS"],"gpt_icon":0},{"id":"2610644910","title":"Pharvaris Unveils Positive Phase 3 RAPIDe-3 Data for Deucrictibant in HAE Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2610644910","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610644910?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:50","pubTimestamp":1770724218,"startTime":"0","endTime":"0","summary":"Pharvaris NV has announced the acceptance of six abstracts for poster presentation at the American Academy of Allergy, Asthma & Immunology  2026 Annual Meeting, scheduled to take place from February 27 to March 2, 2026, in Philadelphia, PA. Among the data to be presented are pivotal Phase 3 results from the RAPIDe-3 study evaluating deucrictibant for the on-demand treatment of hereditary angioedema  attacks, as well as final data from the open-label portion of the Phase 2 CHAPTER-1 study assessing deucrictibant for prophylaxis of HAE attacks. Additional presentations will include pharmacokinetic data on an extended-release deucrictibant tablet, findings from a novel kinin biomarker assay, and endpoint validation results. The company noted that the posters and presentation slides will be made available online at the start of each respective presentation. Topline data from the pivotal Phase 3 CHAPTER-3 study of deucrictibant for long-term HAE prophylaxis are anticipated in the third quar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL1Q9GYl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4588","BK4007","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2095319765.USD","PHVS","SG9999014005.SGD","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","BK4585","LU0314104364.USD","NDAQ","SG9999014013.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2608862974","title":"Morgan Stanley Reaffirms Their Buy Rating on Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608862974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608862974?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:57","pubTimestamp":1770040640,"startTime":"0","endTime":"0","summary":"In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Pharvaris, with a price target of $41.00. Skor covers the H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-pharvaris-phvs-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-pharvaris-phvs-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS"],"gpt_icon":0},{"id":"2606127068","title":"Assessing Pharvaris (PHVS) Valuation After Earnings Beat And Renewed Analyst Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2606127068","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606127068?lang=en_us&edition=fundamental","pubTime":"2026-01-27 11:25","pubTimestamp":1769484341,"startTime":"0","endTime":"0","summary":"Why Pharvaris Stock Is Back on Traders’ Radars\nPharvaris (PHVS) has drawn fresh attention after a quarterly earnings report that surpassed analysts’ consensus expectations, followed by multiple brokerages reiterating positive ratings and increasing their estimates for the stock.\nSee our latest analysis for Pharvaris.\nAfter the recent earnings surprise and upbeat broker commentary, Pharvaris has kept positive momentum, with a 21.81% 90 day share price return and a 53.11% 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/assessing-pharvaris-phvs-valuation-after-earnings-beat-and-r","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/assessing-pharvaris-phvs-valuation-after-earnings-beat-and-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PHVS"],"gpt_icon":0},{"id":"2606124351","title":"Analysts Conflicted on These Healthcare Names: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606124351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606124351?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:21","pubTimestamp":1769433691,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG – Research Report), Pharvaris (PHV...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-galapagos-glpg-pharvaris-phvs-and-stevanato-group-stvn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-galapagos-glpg-pharvaris-phvs-and-stevanato-group-stvn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","BK4139","BK4588","GLPG","STVN","BK4539","LU0128526141.USD","BK4137","BK4007","PHVS","XBI","XLV","BK4121","LU0029874061.USD","LABU","HCSG"],"gpt_icon":0},{"id":"2602512630","title":"Pharvaris Sets 2026 Roadmap as Deucrictibant Advances Toward NDA Filing and Phase 3 Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512630","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512630?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:17","pubTimestamp":1768220253,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Pharvaris ( ($PHVS) ). On January 12, 2026, Pharvaris outlined its 2026 strategic priorities centered on advanc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharvaris-sets-2026-roadmap-as-deucrictibant-advances-toward-nda-filing-and-phase-3-readouts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharvaris-sets-2026-roadmap-as-deucrictibant-advances-toward-nda-filing-and-phase-3-readouts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2602511798","title":"Pharvaris joins Nasdaq Biotechnology Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2602511798","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602511798?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:50","pubTimestamp":1768218609,"startTime":"0","endTime":"0","summary":"Pharvaris NV has been added to the Nasdaq Biotechnology Index  as of December 2025. Inclusion in the NBI requires companies to meet eligibility criteria such as minimum market capitalization, average daily trading volume, and sufficient time as a public company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL9fL2bq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","PHVS","SG9999014005.SGD","LU2095319765.USD","LU0314104364.USD","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4112","BK4007","NDAQ","SG9999014013.SGD","LU2210150020.SGD","SG9999014039.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2602951126","title":"Pharvaris Outlines 2026 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602951126","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602951126?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:50","pubTimestamp":1768218600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA126SML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2602511757","title":"Pharvaris Nv - Estimated Cash Runway Into H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2602511757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602511757?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:50","pubTimestamp":1768218600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA126SML:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2602117685","title":"Pharvaris Nv - Topline Data From Chapter-3 Study Expected in 3Q2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602117685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602117685?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:50","pubTimestamp":1768218600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA126SML:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2602117525","title":"Pharvaris Nv - Nda Filing for Deucrictibant Expected in 1H2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602117525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602117525?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:50","pubTimestamp":1768218600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA126SML:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2589582106","title":"Pharvaris (PHVS): Reassessing Valuation After Strong RAPIDe-3 Phase 3 Success in Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2589582106","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589582106?lang=en_us&edition=fundamental","pubTime":"2025-12-07 02:14","pubTimestamp":1765044857,"startTime":"0","endTime":"0","summary":"Pharvaris (NasdaqGS:PHVS) just cleared a major clinical hurdle, with its RAPIDe-3 Phase 3 trial of oral deucrictibant hitting all primary and secondary endpoints in hereditary angioedema. The company intends to use these data as the basis for 2026 approval filings.\nSee our latest analysis for Pharvaris.\nEven with the recent pullback, including a 1 day share price return of minus 4.6 percent and minus 6.9 percent over 7 days, Pharvaris still shows building momentum with a 30 day share price...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-reassessing-valuation-after-strong-rapide-3-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/pharvaris-phvs-reassessing-valuation-after-strong-rapide-3-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","PHVS","DCF"],"gpt_icon":0},{"id":"2589835185","title":"Pharvaris' Phase 3 Trial of Deucrictibant for HAE Attacks Confirms a Differentiated On-Demand Profile, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2589835185","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589835185?lang=en_us&edition=fundamental","pubTime":"2025-12-05 00:00","pubTimestamp":1764864034,"startTime":"0","endTime":"0","summary":"Pharvaris'  phase 3 trial of deucrictibant for hereditary angioedema attacks meeting primary and secondary endpoints confirms a differentiated oral on-demand profile, Morgan Stanley said in a Wednesday note.The company remains on track for new drug application submission to the US Food and Drug Administration in H1 2026, with the prophylactic data readout from the ongoing chapter-3 phase 3 study expected in H2 2026, according to the note.The firm said that the prophylactic opportunity is larger than on-demand, with Pharvaris guiding to 67% of the population at present, growing to around 80% in terms of value in the prophylactic space.The firm said it modeled a 65% probability of success for the prophylactic candidate and a 90% probability of success for the on-demand candidate.Morgan Stanley raised the company's price target to $41 from $37, with an overweight rating.Price: 28.16, Change: -1.21, Percent Change: -4.10","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1074936037.SGD","LU1244550494.USD","LU2089284900.SGD","LU1732800096.USD","LU2347655156.SGD","LU1791710400.SGD","LU1989772840.SGD","LU0006306889.USD","BK4585","LU2028103732.USD","LU0106261372.USD","IE00BKVL7J92.USD","IE00B64QTZ34.USD","LU2023251221.USD","LU2089283258.USD","BK4588","LU1169590202.USD","LU1989772923.USD","LU0106831901.USD","LU0528227936.USD","LU0098860793.USD","LU0205194284.USD","LU1244550577.SGD","LU2271345857.HKD","HAE","PHVS","LU0557290698.USD","LU2357305700.SGD","BK4504","LU0795875169.SGD","LU0882574139.USD","LU1791710582.SGD","LU0158827781.USD","BK4198","LU1732799900.SGD","LU0971096721.USD","LU0267386448.USD","MS","IE0034390439.USD","IE00BZ1G4Q59.USD","LU1363072403.SGD","LU0106261612.USD","BK4007","IE00B19Z6F94.USD","LU1720051017.SGD","LU0225283273.USD","LU1244550221.USD","LU1548497426.USD","LU0320765646.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"2588882499","title":"Pharvaris Nv : Oppenheimer Raises Target Price to $50 From $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882499?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:31","pubTimestamp":1764855073,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA0XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHVS"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":86,"code":"91000000","status":"200"}]}}